Introduction {#S1}
============

Surgery for hiatal hernia has gone through many developmental stages after the first repair was reported by Soresi in 1926 ([@B1]). The therapy of a large hiatal hernia is far from being established due to the complexity of the anatomical region and the need for improvement of some current methods. In analogy to hernia repair of the abdominal wall, synthetic materials were used to repair hiatal hernia to reduce the risk for hernia recurrence ([@B2]). Despite the lower recurrence rates in comparison to direct suture ([@B3]), there were significant long-term complications due to local fibrosis, stricture formation around the prosthetic material, esophageal erosion, mesh migration, and late dysphagia ([@B4]). To solve these problems, biological meshes from human acellular cadaveric dermis (HACD), porcine small intestine submucosa (SIS), porcine dermal collagen (PDC), or bovine pericardium were developed. HACD and SIS have been utilized as mesh grafts for hiatal hernia repair ([@B5]). It is assumed that the natural tissue texture of the biologic mesh results in less esophageal erosions and lowers the risk of complications. Less inflammation and reduced fibrotic tissue changes at the hiatus should lead to a better quality of life, specifically lower dysphagia rates ([@B6]).

This study aims to assess the clinical result of patients with large hiatal hernia after repair with a biologic mesh.

Patients and Methods {#S2}
====================

A consecutive number of patients, who were diagnosed with large hiatal hernia and thoracic stomach, underwent surgery between 2010 and 2014. Pre- and postoperative work-up included symptoms assessment, barium swallow, endosopy, and CT scan. The large hiatal hernias were anatomically classified as types III and IV and clinically as type 2dII according to Koch et al. ([@B7]). Using the formula given by Granderath ([@B8]), the hiatal surface area was calculated intraoperatively as 13.5 ± 4.5 cm^2^, which is well in the range of large mixed-type hiatal hernia ([@B9]).

The CT scan in Figure [1](#F1){ref-type="fig"} and the intraoperative picture in Figure [2](#F2){ref-type="fig"} demonstrate a representative finding of a large hiatal hernia with an upside-down stomach.

![**Preoperative computed tomography of the upside-down stomach of a 73-year-old male with the gastroesophageal junction being fully dislocated into the thoracic cavity (arrow)**.](fsurg-03-00016-g001){#F1}

![**Situs of a large hiatal hernia in this 72-year-old male operated on 2 years ago**. The upside-down stomach is fully encased in both loose and dense adhesions.](fsurg-03-00016-g002){#F2}

Surgery was conducted in the Asklepios Klinikum Harburg in Hamburg, a teaching hospital of the University of Hamburg, and the Asklepios Medical School. All patients complained of unbearable mass reflux with regurgitation of acid material preoperatively. Eight patients complained of the inability to sustain their weight due to dysphagia. Five patients were subsequently unable to conduct routine daily life, such as gardening, wiping of the floor, cycling, etc. One patient suffered from chronic obstructive airway disease and another patient from recurrent pneumonia due to silent aspiration. All hernias were surgically treated by a sutured hiatal repair reinforced with a cross-linked biologic mesh of a porcine acellular dermal collagen matrix (Permacol^®^, Covidien) under general anesthesia. The mesh was placed to circularly enclose the esophagus with an opening of at least 15 mm in diameter. All patients were included prospectively into an inhospital registry. Data including demographics, prior history, and individualized surgical technique were obtained from the patients' charts and surgical reports. The postoperative progress, the patients' complaints, and the recurrence status were recorded at regular intervals of maximally 1 year. All case notes were reviewed to determine follow-up and to check specifically whether a recurrence occurred or any further unplanned surgery or endoscopy was required. The current status to date was supplemented by a telephone interview.

Surgical Procedures {#S2-1}
-------------------

Both laparoscopic and conventional methods were used. The principle was the same: the closure of the paraesophageal hernia using a 10 cm × 10 cm and 1-mm thick biologic mesh of a porcine acellular dermal collagen matrix (Permacol^®^ and Covidien). The surgical technique has previously been described ([@B10]). Briefly, the hiatal hernia repair involves the preparation and resection of the sac and reduction and retention of the hernia contents intra-abdominally (Figure [3](#F3){ref-type="fig"}). The reposition of the stomach back to the abdominal cavity was followed by a wide mediastinal mobilization of the distal esophagus to ensure appropriate intra-abdominal length to prevent the stomach from sliding back up. Retention was achieved with a posterior hiatoplasty (Figure [4](#F4){ref-type="fig"}) using non-absorbable sutures (Ethibond 0, Ethicon, Norderstedt, Germany). Additionally, a short floppy Nissen's fundoplication was executed and sutured in place again using Ethibond 0 as three interrupted stitches encircling the intra-abdominal esophagus for 25 mm (Figure [5](#F5){ref-type="fig"}). The closure of the hiatus was supported with the quadratic biologic mesh. The mesh was tailored to the individual anatomy by rounding the edges, placed on the diaphragmal crura from the abdominal side, sutured into place with at least four non-absorbable sutures (Ethibond 0), and reinforced with fibrin sealant (Evicel^®^, Ethicon^®^, Norderstedt, Germany) (Figure [6](#F6){ref-type="fig"}).

![**Preparation of the hiatal sac with the right and the left crus of the diaphragm prepared in their ventral aspect (arrows)**.](fsurg-03-00016-g003){#F3}

![**A hiatoplasty is formed with three evenly spaced non-absorbable sutures (Ethibond 0, Ethicon, Norderstedt, Germany, arrows)**. The distal esophagus is encircled with a silastic band and held to the left. At this point of time, a 54-Ch Rüsch tube is passed through the esophagogastric junction and a 5-mm instrument is additionally placed from the left into the newly formed hiatus in order to ensure sufficient space for the passage of food. A similar instrument is placed at the low left corner of the picture for comparison of sizes. Another 5-mm instrument is inserted from the right in order to lift the ventral crural junction to facilitate instrumentation.](fsurg-03-00016-g004){#F4}

![**Short floppy Nissen's fundoplication in place with the top suture fixing the stomach, esophagus, and right hiatal leg (white arrow)**.](fsurg-03-00016-g005){#F5}

![**Hiatal region of a 75-year-old female patient 1 year after implantation of the Permacol^®^ mesh as described above**. The arrows show the position of the mesh. An upper endoscopy showed a mild gastritis without signs of esophageal reflux at this time.](fsurg-03-00016-g006){#F6}

Results {#S3}
=======

During the study period, 13 patients were surgically treated for a thoracic stomach. Among them one patient passed away in the meantime from coronary heart disease. Additionally, two patients were lost to follow-up by moving to an unknown destination -- they could not be located either by searching their medical records or by contacting their primary care physicians, leaving a total of 10 patients for further study. There were three (30%) men and seven (70%) women with a median age of 73 ± 13 years (range: 26--81).

The mean follow-up was 27 ± 18 months (range: 3--58). The patients underwent in four cases an open procedure twice due to respiratory and once due to cardiocirculatory instability upon laparoscopy. In one case, the laparoscopic approach had to be converted to a combined laparotomy and left-sided thoracotomy due to the inability to reduce the completely intrathoracic stomach in the abdominal cavity. In six cases, a laparoscopic procedure was performed as described above. A total of 20% (2 of 10) underwent one further, unplanned surgery after the prior therapy; in one case, the mesh was explantated because of dysphagia and pain due to dense fibrosis surrounding the mesh. In the other case, pain due to peritoneal adhesions was found unrelated to the sufficient hiatoplasty with mesh enforcement. In the latter case, first, a gastritis was found on repeat gastrocopy, and later, a Herpes zoster infection was elucidated. On an intercurrent computed tomography scan, the mesh was found in place but appears thickened (arrows in Figure [7](#F7){ref-type="fig"} below). Measuring the mesh from the scans, a 5-mm plate resulted from the 1-mm mesh in this case.

![**Permacol^®^ reinforment of the hiatoplasty shown above**. The Permacol^®^ is secured with non-absorbable interrupted stitches and additionally fastened with fibrin glue (Evicell^®^) in critical areas (white arrow).](fsurg-03-00016-g007){#F7}

In this case, a pyloroplasty was performed because of gastroparesis without complete relief of symptoms. Since the patient can keep a normal weight, she is reluctant to any further surgical treatment. There were no other major complications. A total of six patients underwent upper endoscopy because of various complaints, such as burning, intra-abdominal pain, regurgitation, and dysphagia. Except for one case with a stenosis bettered by balloon dilatation and the one reported with a small recurrence, there were no pathological findings related to the hiatal repair.

Four patients (40%) complained about dysphagia postoperatively. In one case, the symptoms declined spontaneously within 6 months. Another patient successfully underwent esophageal dilatation of a stenosis 2 months postoperatively. Up to this date, two patients (20%) still report mild dysphagia but maintain normal body weight. Four cases report persistent intra-abdominal discomfort without weight loss. Three patients experienced bloating, while another patient reported reflux. In another case, regurgitation was described by the patient without abnormal endoscopic findings. The symptoms are summarized in Table [1](#T1){ref-type="table"}.

###### 

**Summary of the status after 2 years (multiple declarations possible)**.

  Symptom                  Cases% (*n*)
  ------------------------ --------------
  Pain                     30 (3)
  Bloating                 30 (3)
  Dysphagia                20 (2)
  Gastroparesis            10 (1)
  Reflux with recurrence   10 (1)
  Regurgitation            10 (1)

Discussion {#S4}
==========

The treatment of large and giant hiatal hernias has been a challenge, since it is both technically more difficult and has always substantially elevated recurrence rates ([@B10]--[@B12]). Laparoscopic hiatal hernia repair for larger hernias seem to have even higher recurrence rates leading to revision surgery ([@B13]). Primary suture hiatoplasty without reinforcement is associated with high recurrence rates, so that a variety of meshes has been developed to reduce the risk of recurrence ([@B11]). The main concern using a synthetic mesh is the risk of specific complications through the local erosion into the stomach, fibrosis, mesh contraction, and esophageal stenosis, which are thought to cause higher dysphagia rates ([@B4], [@B14]--[@B19]). Synthetic meshes are associated with a higher risk of esophageal resection at revision surgery ([@B4], [@B20]). In order to minimize these side effects, biologic meshes from human cadaveric dermis and SIS have been developed. A mild inflammatory response and neovascularization were reported for the biologic grafts ([@B21]--[@B23]). It is believed that a limited foreign body reaction at the hiatus due to their biocompatibility minimizes the risk of postoperative dysphagia ([@B24]).

Among the US surgeons who use mesh to repair the hiatal hernia, 67% prefer biologic mesh ([@B25]). The recurrence rates following a biological mesh hiatoplasty can vary in the literature between 0 and 54%, with a median value of 10% (Table [2](#T2){ref-type="table"}). These recurrence rates are almost identical to those found after hiatal repair using synthetic meshes (range: 0--35, median 7%). In this study, large hiatal hernias were repaired using a cross-linked collagen matrix derived from pig tissue.

###### 

**Pre- and postoperative data from published hiatal repairs embracing the esophagus and reinforcing only the crural repair**.

  Author                                        Year   Mesh type                            Patients   Hernia type   Dysphagia preoperatively (%)   Follow-up (months)   Recurrence (%)   Dysphagia 1--2 years postoperatively (%)
  --------------------------------------------- ------ ------------------------------------ ---------- ------------- ------------------------------ -------------------- ---------------- ------------------------------------------
  **Mesh placement encircling the esophagus**                                                                                                                                             
  Hazebroek ([@B26])                            2008   TiMesh                               18         II--IV        22                             24                   6                41
  Carlson ([@B27])                              1999   PTFE                                 15         III--IV       na                             30                   0                na
  Frantzides ([@B28])                           2002   PTFE                                 36         III--IV       na                             30                   0                na
  Lubezky ([@B29])                              2007   PTFE/ePTFE                           45         III--IV       17                             28                   13               20
  Stavropoulos ([@B30])                         2012   ePTFE                                38         II--IV        na                             24                   na               na
  Zaninotto ([@B31])                            2007   Polypropylene/ePTFE                  35         III           na                             71                   9                22
  Gouvas ([@B32])                               2011   Polypropylene/PTFE                   20         II--IV        84                             36                   15               19
  Chilintseva ([@B33])                          2012   PTFE/polyester/polypropylene/ePTFE   45         I--IV         7                              51                   4                11
  Oelschläger ([@B34])                          2003   SIS                                  9          II--III       33                             8                    0                13
  Jacobs ([@B35])                               2007   SIS                                  92         I--III        na                             38                   3                11
  Massullo ([@B36])                             2012   Polyglycolic:trimethylene            11         I--III        na                             13                   9                0
  Present paper                                 2015   Cross-linked acellular pig dermis    10         III--IV       80                             26                   10               20
  **Mesh placement avoiding the esophagus**                                                                                                                                               
  Watson ([@B37])                               2015   TiMesh                               42         III--IV       19                             12                   23               7
  Gryska ([@B38])                               2005   PTFE                                 130        I--III        na                             48                   8                0
  Hazebroek ([@B26])                            2009   ePTFE                                14         II--III       16                             34                   29               27
  Champion ([@B39])                             2003   Polypropylene                        19         II--III       na                             25                   5                11
  Leeder ([@B40])                               2003   Polypropylene                        14         I--III        93                             46                   14               0
  Horstmann ([@B41])                            2004   Polypropylene                        16         II--III       31                             14                   0                na
  Granderath ([@B42])                           2006   Polypropylene                        150        II--IV        na                             12                   8                4
  Turkcapar ([@B43])                            2007   Polypropylene                        156        I--II         na                             24                   2                1
  Soricelli ([@B44])                            2009   Polypropylene                        91         II--III       na                             69                   2                0
  Morino ([@B45])                               2006   Polypropylene/PTFE                   37         I--III        na                             36                   35               0
  Grubnik ([@B46])                              2013   Polypropylene-Monocryl               158        II--IV        na                             28                   5                2
  Goers ([@B47])                                2011   Various biomeshes                    40         II--IV        na                             6                    0                38
  Molena ([@B48])                               2015   Various biomeshes                    18         III--IV       na                             na                   na               na
  Ringley ([@B49])                              2006   HACD                                 22         II--IV        0                              7                    0                6
  Wisbach ([@B50])                              2006   HACD                                 11         III           55                             24                   11               18
  Lee ([@B51])                                  2007   HACD                                 17         I--III        na                             14                   12               6
  Lee ([@B52])                                  2008   HACD                                 52         na            44                             24                   4                na
  Diaz ([@B53])                                 2011   HACD                                 26         II--III       13                             24                   15               23
  Alicuben ([@B54])                             2014   HACD                                 15         II--IV        na                             12                   20               13
  **Mesh placement avoiding the esophagus**                                                                                                                                               
  Jacobs ([@B35])                               2007   SIS                                  74         na            na                             38                   4                na
  Fumagalli ([@B55])                            2008   SIS                                  6          na            na                             12                   50               13
  Oelschlager ([@B56])                          2011   SIS                                  33         II--III       3                              58                   54               3
  Wassenaar ([@B57])                            2012   SIS                                  31         I--IV         na                             45                   3                20
  Watson ([@B37])                               2015   SIS                                  41         III--IV       27                             12                   23               9
  Wang ([@B58])                                 2015   SIS and alike                        66         I--III        6                              24                   13               4

*na, not available*.

According to a retrospective analysis of hiatal revisions following synthetic or biologic mesh application, there were no significant differences in terms of blood loss, duration of surgery, morbidity, and need for esophageal reconstruction ([@B17]). The recurrence rate can be significantly reduced from 16 to 0% with the use of an absorbable mesh for the repair of small hiatal hernia ([@B23]). In a study of 108 patients, the recurrence rate was reduced from 24 to 9% with the laparoscopic use of a biologic mesh compared to the suture of the hiatus ([@B7]). A new meta-analysis confirmed the lower recurrence rates for the biologic mesh in the short-term, but the long-term benefit remains unclear ([@B24]). The repair of large hiatal hernias with biologic mesh may be associated with a lower risk for short-term recurrence compared to primary suture repair. Short-term recurrence rates for suture repair and biologic mesh repair ranged in a meta-analysis between 16.6 and 3.5%, respectively. The same study showed that the long-term recurrence based on data provided by one trial only was 51.3 and 42.4%, respectively ([@B25]). In our study, the recurrence rate was 10% after a median time of 27 months. The recurrence rate after the use of SIS can be up to 9% ([@B26]). Another large study with 92 patients treated with SIS achieved a recurrence rate of 3.3% and a dysphagia rate of 8.6% in a median follow-up of 3.3 years ([@B27]). The incidence of postoperative dysphagia in 22 patients after treatment with human acellular dermal matrix was 4.5% ([@B28]). In our study, 40% of the patients complaint postoperatively about dysphagia. Up to now and after successful endoscopic dilatation in one case, 20% of the patients still have the sensation of dysphagia but keep their weight.

Since dysphagia impairs the quality of life significantly, an attempt is made to further elucidate potential associations. In Table [2](#T2){ref-type="table"}, data are accumulated from the available literature attempting an assessment at a certain postoperative period, namely, 1--2 years as observed in this manuscript. The data are divided in biological and synthetic meshes using techniques embracing the esophagus in order to reduced long-term recurrence rate or excluding the esophagus in an attempt to preserve its function. Since it cannot be assumed that the data are homogenously distributed, the Mann--Whitney *U*-test was used to evaluate group differences. Neither the preoperative dysphagia rate nor the placement of the mesh influences the dysphagia rate significantly although meshes encircling the esophagus tend to exhibit higher dysphagia rates (Table [2](#T2){ref-type="table"}, *p* = 0.126). The length of the follow-up and the rate of recurrence or dysphagia are unrelated in all groups (Table [2](#T2){ref-type="table"}, *p* = 0.667). In both synthetic and biological meshes embracing the esophagus, there is a trend toward elevated dysphagia rates with increasing recurrence rates (Table [2](#T2){ref-type="table"}, *p* = 0.021). In reconstructions avoiding at least half of the circumference, synthetic meshes increase dysphagia as recurrences occur \[Table [2](#T2){ref-type="table"}; Figure [8](#F8){ref-type="fig"}, *r* = 0.63, small effect according to Thalheimer and Cook ([@B59])\]. In contrast, biological meshes decrease dysphagia rates as recurrences occur \[Table [2](#T2){ref-type="table"}; Figure [9](#F9){ref-type="fig"}, *r* = −0.728, intermediate effect according to Thalheimer and Cook ([@B59])\]. The results should be viewed with caution but can be interpreted that the integration of biological meshes in reconstructions avoiding the esophagus decreases dysphagia increasing recurrences within the first 2 years.

![**Dysphagia rates as a function of recurring hiatal hernia after 1--2 years using synthetic meshes leaving at least half of the circumference of the esophagus to move freely (data from Table [2](#T2){ref-type="table"})**. The line indicates the trendline.](fsurg-03-00016-g008){#F8}

![**Dysphagia rates as a function of recurring hiatal hernia after 1--2 years using biological meshes leaving at least half of the circumference of the esophagus to move freely (data from Table [2](#T2){ref-type="table"})**. The line indicates the trendline.](fsurg-03-00016-g009){#F9}

In a recent study with 49 patients, 8% required endoscopic dilatation with a successful resolution of the symptoms ([@B60]). Interestingly, hiatal hernia repair with biomesh fails to increase the postoperative dysphagia rate compared to suture repair alone ([@B6]). The reported rates of dysphagia with synthetic meshes vary between 0 and 41%, with a median of 15.5% \[Table [2](#T2){ref-type="table"} ([@B24], [@B61]--[@B63])\].

Most patients with a recurrent paraesophageal hernia still experience an improvement of clinical symptoms compared to the preoperative status ([@B63], [@B64]). Despite the high recurrence rate up to 54% after a laparoscopic repair of the hiatus with or without mesh, there can be a significant improvement in all parameters assessing the quality of life ([@B10]). This can be due to the smaller sac of the recurrent hernia compared to the original size with a diminished risk of volvulus, obstruction, and ischemia. Our findings demonstrate, in general, that gastrointestinal symptoms associated with big paraesophageal hernias and thoracic stomach, such as postprandial obstruction and pain, are significantly improved after a mesh repair up to 58 months following the surgical closure and reinforcement with the biomesh Permacol^®^. However, price and limited use, e.g., for religious reasons should be weighed against the potential of the biomesh.

Cross-linked collagen matrices have a more coordinated structure and therefore can sustain higher loads for longer times compared to non-cross-linked ones ([@B60], [@B65]). Several studies showed that cross-linking does not appear to affect the tissue integration in animal models or human ([@B60], [@B65], [@B66]). Mesh fibrosis may occur potentially increasing the stiffness of the repair (as demonstrated in a postoperative CT scan, Figure [7](#F7){ref-type="fig"}). Late onset dysphagia even in mesh positions avoiding the esophagus might be related to this scar formation ([@B60]). It remains unclear whether cross-linking contributes to fibrotic changes since we know that resorption is delayed. Permacol™ is a porcine-derived acellular dermal sheet, which is composed predominantly of type I collagen (93--95%). During the manufacturing process, the cellular components are removed and the collagen of the dermis is treated with hexamethylene diisocyanate (HMDI) to increase the degree of cross-linking. It is currently used for the repair of abdominal and thoracic wall defects and for hernias ([@B60]). To prevent mesh dislocation, meshes must be fixated ([@B67]). So far, little is known how to best fasten a hernia mesh in the hiatal position. There are many different ways to anchor a mesh, such as non-absorbable sutures, tacks, or fibrin sealant ([@B61]). We prefer a limited number of sutures and add fibrin glue as shown in Figure [6](#F6){ref-type="fig"} in order to achieve a maximal pliability still holding the mesh in place at the same time. Since the mesh can be placed in at least six different positions, the best placement is still unknown. Most surgeons place a mesh in a U-shape or a pantaloon collar in a retroesophageal position with the limbs of the mesh encircling the esophagus \[Table [2](#T2){ref-type="table"} ([@B10]--[@B64])\]. Data depicted in Figures [8](#F8){ref-type="fig"} and [9](#F9){ref-type="fig"} indicate a different behavior of synthetic and biologic meshes when the esophagus is not fully encircled. On the one hand, patients with smaller (up to 5 cm) hiatal hernias may benefit from the use of a biologic mesh for the repair ([@B61], [@B64], [@B68]). On the other hand, larger hernias are more prone to develop recurrences, even with mesh reinforcement ([@B68]). At this point of time, the preferred technique, the superior mesh position, or the outstanding material still awaits future investigation.

Conclusion {#S5}
==========

The principle of hiatal hernia repair aims to eliminate the hernia preserving the functionality of the gastroesophageal junction at the same time. The use of a biologic mesh to repair large hiatal hernias is an effective method with low recurrence rates. It can reduce the local inflammation and postoperative dysphagia compared to synthetic meshes. Our study demonstrates that local fibrosis and thickening of the mesh can affect the outcome being associated with abdominal discomfort despite a successful repair. The review of the literature indicates comparable results after 2 years with both biologic and synthetic meshes embracing the esophagus. At the same point of time, reconstruction with synthetic and biologic materials differs when the esophagus is not or only partially encircled in the repair.
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